Last reviewed · How we verify

NCT05186519

Amputation Associated Factors and Prediction Model in Diabetic Foot Patients

Completed Last updated 11 January 2022
What this trial tests

trial in Diabetic Foot in 300 participants. Completed in 15 October 2021.

Timeline
1 January 2015
Primary endpoint
15 October 2021
15 October 2021

Quick facts

Lead sponsorQianfoshan Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment300
Start date1 January 2015
Primary completion15 October 2021
Estimated completion15 October 2021
Sites1 location across China

Conditions studied

Sponsor

Qianfoshan Hospital

Who can join

18 and older, any sex, with Diabetic Foot. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diabetic foot can lead to adverse consequences such as amputation and death, which seriously endangering the physical and mental health and quality of life for patients. The aim of this study is to assess factors associated with the occurrence of amputation events in the diabetic foot patients based on a retrospective cohort and to construct a prediction model for patients at high amputated risk.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetic Foot

Currently open trials in the same condition.

Other Qianfoshan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05186519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing